These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 33132423)

  • 1. Chronic inflammation as a molecular basis of nonalcoholic steatohepatitis: role of macrophages and fibroblasts in the liver.
    Itoh M; Ogawa Y; Suganami T
    Nagoya J Med Sci; 2020 Aug; 82(3):391-397. PubMed ID: 33132423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of chronic inflammation in the pathogenesis of nonalcoholic steatohepatitis: lessons from a unique mouse model using melanocortin receptor-deficient mice.
    Itoh M; Suganami T; Ogawa Y
    Endocr J; 2021 Jul; 68(7):743-749. PubMed ID: 33967185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intestinally derived bacterial products stimulate development of nonalcoholic steatohepatitis.
    Dornas W; Lagente V
    Pharmacol Res; 2019 Mar; 141():418-428. PubMed ID: 30658094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatocyte nuclear receptor SHP suppresses inflammation and fibrosis in a mouse model of nonalcoholic steatohepatitis.
    Zou A; Magee N; Deng F; Lehn S; Zhong C; Zhang Y
    J Biol Chem; 2018 Jun; 293(22):8656-8671. PubMed ID: 29666185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gliptins Suppress Inflammatory Macrophage Activation to Mitigate Inflammation, Fibrosis, Oxidative Stress, and Vascular Dysfunction in Models of Nonalcoholic Steatohepatitis and Liver Fibrosis.
    Wang X; Hausding M; Weng SY; Kim YO; Steven S; Klein T; Daiber A; Schuppan D
    Antioxid Redox Signal; 2018 Jan; 28(2):87-109. PubMed ID: 28635324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic inflammation as an instigator of fibrosis during non-alcoholic fatty liver disease.
    Katsarou A; Moustakas II; Pyrina I; Lembessis P; Koutsilieris M; Chatzigeorgiou A
    World J Gastroenterol; 2020 May; 26(17):1993-2011. PubMed ID: 32536770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disruption of hepatic small heterodimer partner induces dissociation of steatosis and inflammation in experimental nonalcoholic steatohepatitis.
    Magee N; Zou A; Ghosh P; Ahamed F; Delker D; Zhang Y
    J Biol Chem; 2020 Jan; 295(4):994-1008. PubMed ID: 31831621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crosstalk Between Liver Macrophages and Surrounding Cells in Nonalcoholic Steatohepatitis.
    Li H; Zhou Y; Wang H; Zhang M; Qiu P; Zhang M; Zhang R; Zhao Q; Liu J
    Front Immunol; 2020; 11():1169. PubMed ID: 32670278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macrophages in Nonalcoholic Fatty Liver Disease: A Role Model of Pathogenic Immunometabolism.
    Krenkel O; Tacke F
    Semin Liver Dis; 2017 Aug; 37(3):189-197. PubMed ID: 28847030
    [No Abstract]   [Full Text] [Related]  

  • 10. Nonalcoholic Fatty Liver Disease: Basic Pathogenetic Mechanisms in the Progression From NAFLD to NASH.
    Pierantonelli I; Svegliati-Baroni G
    Transplantation; 2019 Jan; 103(1):e1-e13. PubMed ID: 30300287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD11c+ resident macrophages drive hepatocyte death-triggered liver fibrosis in a murine model of nonalcoholic steatohepatitis.
    Itoh M; Suganami T; Kato H; Kanai S; Shirakawa I; Sakai T; Goto T; Asakawa M; Hidaka I; Sakugawa H; Ohnishi K; Komohara Y; Asano K; Sakaida I; Tanaka M; Ogawa Y
    JCI Insight; 2017 Nov; 2(22):. PubMed ID: 29202448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular pathways of nonalcoholic fatty liver disease development and progression.
    Bessone F; Razori MV; Roma MG
    Cell Mol Life Sci; 2019 Jan; 76(1):99-128. PubMed ID: 30343320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gemcabene downregulates inflammatory, lipid-altering and cell-signaling genes in the STAM™ model of NASH.
    Oniciu DC; Hashiguchi T; Shibazaki Y; Bisgaier CL
    PLoS One; 2018; 13(5):e0194568. PubMed ID: 29847555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of Fibrosis Development in Nonalcoholic Steatohepatitis.
    Schwabe RF; Tabas I; Pajvani UB
    Gastroenterology; 2020 May; 158(7):1913-1928. PubMed ID: 32044315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging Roles of T Cells in the Pathogenesis of Nonalcoholic Steatohepatitis and Hepatocellular Carcinoma.
    Hirsova P; Bamidele AO; Wang H; Povero D; Revelo XS
    Front Endocrinol (Lausanne); 2021; 12():760860. PubMed ID: 34777255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Galectin-3 and IL-33/ST2 axis roles and interplay in diet-induced steatohepatitis.
    Pejnovic N; Jeftic I; Jovicic N; Arsenijevic N; Lukic ML
    World J Gastroenterol; 2016 Nov; 22(44):9706-9717. PubMed ID: 27956794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progression of non-alcoholic steatosis to steatohepatitis and fibrosis parallels cumulative accumulation of danger signals that promote inflammation and liver tumors in a high fat-cholesterol-sugar diet model in mice.
    Ganz M; Bukong TN; Csak T; Saha B; Park JK; Ambade A; Kodys K; Szabo G
    J Transl Med; 2015 Jun; 13():193. PubMed ID: 26077675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic transcriptome signatures in patients with varying degrees of nonalcoholic fatty liver disease compared with healthy normal-weight individuals.
    Suppli MP; Rigbolt KTG; Veidal SS; Heebøll S; Eriksen PL; Demant M; Bagger JI; Nielsen JC; Oró D; Thrane SW; Lund A; Strandberg C; Kønig MJ; Vilsbøll T; Vrang N; Thomsen KL; Grønbæk H; Jelsing J; Hansen HH; Knop FK
    Am J Physiol Gastrointest Liver Physiol; 2019 Apr; 316(4):G462-G472. PubMed ID: 30653341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macrophages as Key Players during Adipose Tissue-Liver Crosstalk in Nonalcoholic Fatty Liver Disease.
    Korf H; Boesch M; Meelberghs L; van der Merwe S
    Semin Liver Dis; 2019 Jul; 39(3):291-300. PubMed ID: 31041786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrophages and scavenger receptors in obesity-associated non-alcoholic liver fatty disease (NAFLD).
    Kragh Petersen S; Bilkei-Gorzo O; Govaere O; Härtlova A
    Scand J Immunol; 2020 Nov; 92(5):e12971. PubMed ID: 32892401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.